Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB-4 index in metabolic-associated fatty liver disease期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB-4 index in metabolic-associated fatty liver disease

Authors:	Masaaki Mino Eiji Kakazu Akitoshi Sano Hisayuki Katsuyama Mariko Hakoshima Hidekatsu Yanai Yoshihiko Aoki Masatoshi Imamura Taiji Yamazoe Taizo Mori Sachiyo Yoshio Jun Inoue Atsushi Masamune Tatsuya Kanto

Affiliation:	1. Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan;2. Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan;3. Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan;4. Department of Liver Diseases, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Tokyo, Japan;5. Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan Department of Liver Diseases, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Tokyo, Japan

Abstract:

Keywords:	diabetes mellitus fibrosis Fibrosis-4 index metabolic dysfunction-associated fatty liver disease sodium glucose cotransporter 2 inhibitor